306 related articles for article (PubMed ID: 19164451)
1. Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene.
Kalea AZ; Reiniger N; Yang H; Arriero M; Schmidt AM; Hudson BI
FASEB J; 2009 Jun; 23(6):1766-74. PubMed ID: 19164451
[TBL] [Abstract][Full Text] [Related]
2. Complex tissue-specific patterns and distribution of multiple RAGE splice variants in different mammals.
López-Díez R; Rastrojo A; Villate O; Aguado B
Genome Biol Evol; 2013; 5(12):2420-35. PubMed ID: 24273313
[TBL] [Abstract][Full Text] [Related]
3. Expression of a novel secreted splice variant of the receptor for advanced glycation end products (RAGE) in human brain astrocytes and peripheral blood mononuclear cells.
Park IH; Yeon SI; Youn JH; Choi JE; Sasaki N; Choi IH; Shin JS
Mol Immunol; 2004 Mar; 40(16):1203-11. PubMed ID: 15104125
[TBL] [Abstract][Full Text] [Related]
4. Identification, classification, and expression of RAGE gene splice variants.
Hudson BI; Carter AM; Harja E; Kalea AZ; Arriero M; Yang H; Grant PJ; Schmidt AM
FASEB J; 2008 May; 22(5):1572-80. PubMed ID: 18089847
[TBL] [Abstract][Full Text] [Related]
5. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.
Yonekura H; Yamamoto Y; Sakurai S; Petrova RG; Abedin MJ; Li H; Yasui K; Takeuchi M; Makita Z; Takasawa S; Okamoto H; Watanabe T; Yamamoto H
Biochem J; 2003 Mar; 370(Pt 3):1097-109. PubMed ID: 12495433
[TBL] [Abstract][Full Text] [Related]
6. Tissue-specific expression patterns of the RAGE receptor and its soluble forms--a result of regulated alternative splicing?
Schlueter C; Hauke S; Flohr AM; Rogalla P; Bullerdiek J
Biochim Biophys Acta; 2003 Oct; 1630(1):1-6. PubMed ID: 14580673
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing of RAGE: roles in biology and disease.
Kalea AZ; Schmidt AM; Hudson BI
Front Biosci (Landmark Ed); 2011 Jun; 16(7):2756-70. PubMed ID: 21622207
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific expression profiling of receptor for advanced glycation end products and its soluble forms in esophageal and lung cancer.
Jing RR; Cui M; Sun BL; Yu J; Wang HM
Genet Test Mol Biomarkers; 2010 Jun; 14(3):355-61. PubMed ID: 20578941
[TBL] [Abstract][Full Text] [Related]
9. Splice variants of the receptor for advanced glycosylation end products (RAGE) in human brain.
Ding Q; Keller JN
Neurosci Lett; 2005 Jan; 373(1):67-72. PubMed ID: 15555779
[TBL] [Abstract][Full Text] [Related]
10. Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases.
Zhang L; Bukulin M; Kojro E; Roth A; Metz VV; Fahrenholz F; Nawroth PP; Bierhaus A; Postina R
J Biol Chem; 2008 Dec; 283(51):35507-16. PubMed ID: 18952609
[TBL] [Abstract][Full Text] [Related]
11. Alternative splicing of the RAGE cytoplasmic domain regulates cell signaling and function.
Jules J; Maiguel D; Hudson BI
PLoS One; 2013; 8(11):e78267. PubMed ID: 24260107
[TBL] [Abstract][Full Text] [Related]
12. Effect of chronic hypoxia on RAGE and its soluble forms in lungs and plasma of mice.
Gopal P; Gosker HR; Theije CC; Eurlings IM; Sell DR; Monnier VM; Reynaert NL
Biochim Biophys Acta; 2015 May; 1852(5):992-1000. PubMed ID: 25703138
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE).
Hanford LE; Enghild JJ; Valnickova Z; Petersen SV; Schaefer LM; Schaefer TM; Reinhart TA; Oury TD
J Biol Chem; 2004 Nov; 279(48):50019-24. PubMed ID: 15381690
[TBL] [Abstract][Full Text] [Related]
14. Sequencing of two alternatively spliced mRNAs corresponding to the extracellular domain of the rat receptor for advanced glycosylation end products (RAGE).
Girón MD; Vargas AM; Suárez MD; Salto R
Biochem Biophys Res Commun; 1998 Oct; 251(1):230-4. PubMed ID: 9790936
[TBL] [Abstract][Full Text] [Related]
15. Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target.
Geroldi D; Falcone C; Emanuele E
Curr Med Chem; 2006; 13(17):1971-8. PubMed ID: 16842191
[TBL] [Abstract][Full Text] [Related]
16. Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy.
Forbes JM; Thorpe SR; Thallas-Bonke V; Pete J; Thomas MC; Deemer ER; Bassal S; El-Osta A; Long DM; Panagiotopoulos S; Jerums G; Osicka TM; Cooper ME
J Am Soc Nephrol; 2005 Aug; 16(8):2363-72. PubMed ID: 15930093
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms.
Grossin N; Wautier MP; Picot J; Stern DM; Wautier JL
Diabetes Metab; 2009 Nov; 35(5):410-7. PubMed ID: 19815443
[TBL] [Abstract][Full Text] [Related]
18. Cloning, characterisation, and comparative quantitative expression analyses of receptor for advanced glycation end products (RAGE) transcript forms.
Sterenczak KA; Willenbrock S; Barann M; Klemke M; Soller JT; Eberle N; Nolte I; Bullerdiek J; Murua Escobar H
Gene; 2009 Apr; 434(1-2):35-42. PubMed ID: 19061941
[TBL] [Abstract][Full Text] [Related]
19. Soluble RAGE-modulating drugs: state-of-the-art and future perspectives for targeting vascular inflammation.
Lanati N; Emanuele E; Brondino N; Geroldi D
Curr Vasc Pharmacol; 2010 Jan; 8(1):86-92. PubMed ID: 19485931
[TBL] [Abstract][Full Text] [Related]
20. Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression.
Harashima A; Yamamoto Y; Cheng C; Tsuneyama K; Myint KM; Takeuchi A; Yoshimura K; Li H; Watanabe T; Takasawa S; Okamoto H; Yonekura H; Yamamoto H
Biochem J; 2006 May; 396(1):109-15. PubMed ID: 16503878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
